BioSig Technologies, Inc. STEX Loss On Warrant Settlement
Loss On Warrant Settlement at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:LossOnWarrantSettlement.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s loss on warrant settlement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s loss on warrant settlement?
- BioSig Technologies, Inc. (STEX) reported loss on warrant settlement of $2.01M in Q4 2025.
- What does loss on warrant settlement mean?
- This metric captures the financial loss incurred when the company settles outstanding warrants, often due to changes in the underlying stock price or the terms of the warrant agreement. It represents a non-operating expense that can significantly impact net income without reflecting core operational performance. Investors analyze this to understand the dilution risk and the cost of capital associated with equity-linked financing instruments.